Florida-based bio-sciences company changes corporate address
AG Health, a leader in Endocannabinoid Nutrition (ECN)
DORAL, Fla. — Avant-Garde Holdings Americas, Inc., dba AG Health, a bio-sciences company focusing on big data analytics, health information and disease management, bio-pharma drug formulations and E-commerce solutions for the U.S. cannabis and hemp industry, announced Thursday they have moved their corporate headquarters and distribution center to 9590 NW 40th Street Road, Doral, FL 33178.
AG Health, a leader in Endocannabinoid Nutrition (ECN), will now distribute its hemp-derived ECN products under its VEDA brands from its new headquarters. AG Health only uses the highest quality compliant industrial hemp extracts in its proprietary formulations, which are sold in an aqueous spray, tincture, vape and cream formulations.
“Our new corporate facility and increased distribution capability is on pace with our sales ramp up at AG Health. We now have 20,000 square feet of distribution space which will help us serve our distribution channels in the US, the Caribbean, and Central and South America,” said Taryn Berk, COO at AG Health.
A recent report conducted by New Frontier Data estimates the U.S. CBD industry grew by nearly 40 percent in 2017, reaching $367 million in sales across hemp-derived and marijuana-derived markets. This is the first year on record in which sales of hemp-derived CBD products outpaced marijuana-derived products.
Robert Chavez, CEO of AG Health, said that “the added space was necessary to support our rapidly growing sales and expanded product lines, which will only increase with the release of our enhanced E-commerce platform. We needed the space to house our logistics and sales team serving our growing customer base”.
AG Health was founded by a unique group of experts in agricultural science, chemistry, biology, healthcare, and finance. Its VEDA ECN brand was developed to address the overwhelming deficiency in Endocannabinoid Nutrition (ECN) that affects the health and well-being of individuals all over the world.
VEDA products are formulated to provide the highest bioavailability, the most effective delivery systems and to ensure customer accessibility and affordability. Driven by our principles in healthcare, nutrition and wellness, VEDA products were developed to positively and significantly impact global population health. At AG Health, we believe that everyone should have access to quality ECN products to enhance their health and well-being.
VEDA provides a variety of ECN products including; tincture, spray and vape. The VEDA Sports line is set to launch Fall 2018 with, VEDA Pet, and VEDA Hospitality to follow.
VEDA ECN is a division of Avant Garde Holdings Americas, Inc., dba AG Health, a research and development company of bio-pharmaceutical products, big data analytics, health information and disease management, drug formulations and commerce solutions for the U.S. cannabis and hemp industry.